Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer

BACKGROUND: Serial analysis of circulating tumor DNA (ctDNA) levels is a promising tool for both relapse prediction in the curative setting, as well as predicting clinical benefit from systemic treatment in metastasic colorectal cancer (mCRC). Most data in this context are derived from treatment nai...

Descripción completa

Detalles Bibliográficos
Autores principales: Doleschal, Bernhard, Kirchweger, Patrick, Schwendinger, Simon, Kupferthaler, Alexander, Burghofer, Jonathan, Webersinke, Gerald, Jukic, Emina, Wundsam, Helwig, Biebl, Matthias, Petzer, Andreas, Rumpold, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Liquid Biopsy in Gastrointestinal Cancers: circulating tumor DNA (ctDNA) and circulating tumor cell (CTC)-based precision oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541738/
https://www.ncbi.nlm.nih.gov/pubmed/37786537
http://dx.doi.org/10.1177/17588359231200462

Ejemplares similares

Ejemplares similares